Medinotec Inc. MDNC

FY2026 · ended Feb 28, 2026 · Revenue $9.73M, +6.8% YoY · Filed May 28, 2026

Medinotec Inc. (MDNC) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2026, which ended Feb 28, 2026, it reported revenue of $9.7 million and net income of $794,502. Free cash flow was $905,435. As of Aug 31, 2026 it held $2.6 million in cash and investments and $91,165 in total debt.

Revenue (TTM)
$10.21M
-10.7% vs year-ago TTM
Net income (TTM)
$597,032
-73.4% vs year-ago TTM
Operating cash flow (TTM)
$373,899
-45.6% vs year-ago TTM
Free cash flow (TTM)
$303,284
EPS
—
Dividend per share
None
Shares outstanding
11.76M
+0.2% vs prior year
Net cash
$2.49M
as of Aug 31, 2026
Operating margin
6.6%
FY 2027

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
MDNC (OTC)
Fiscal year ends
February 28
Incorporated in
NV
Headquarters
Johannesburg
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1931055

Other Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2026
Feb 28, 2026
FY 2025
Feb 28, 2025
FY 2024
Feb 29, 2024
FY 2023
Feb 28, 2023
Revenue
$9.7M
$9.1M
$5.0M
$999,579
Operating income
$1.1M
$3.2M
$600,578
-$238,587
Net income
$794,502
$2.2M
-$404,688
-$352,735
Operating cash flow
$906,798
$877,834
$14,242
-$490,549
Free cash flow
$905,435
$788,821
$11,987
-$545,826
Total assets
$6.8M
$6.8M
$4.8M
$4.5M
Total liabilities
$1.1M
$2.5M
$2.6M
$1.9M
Stockholders' equity
$5.7M
$4.3M
$2.2M
$2.6M
Cash and investments
$2.8M
$2.8M
$2.8M
$2.8M
Total debt
$14,905
$40,756
$64,014
—

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Oct 8, 2026 Aug 31, 2026
10-Q Quarterly report Jul 9, 2026 May 31, 2026
10-K Annual report May 28, 2026 Feb 28, 2026
8-K Current report
Shareholder vote results
Jan 20, 2026 Jan 20, 2026
10-Q Quarterly report Jan 9, 2026 Nov 30, 2025
10-Q Quarterly report Oct 8, 2025 Aug 31, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.